Omega-3 fish oil prediabetes supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome health.
Go to PubMed and copy the title in the search field.
The effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patients.
Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPAR a/? activity in microvascular endothelial cells.
Relationship between red cell membrane fatty acids and adipokines in individuals with varying insulin sensitivity.
Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.
Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial.
Role of n-3 Longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.
Fatty fish in the diet of patients with type 2 diabetes: comparison of the metabolic effects of foods rich in n-3 and n-6 fatty acids.
>Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study.
Plasma omega-3 fatty acids and incident diabetes in older adults.
A combination of (?-3) polyunsaturated fatty acids, polyphenols and L-carnitine reduces the plasma lipid levels and increases the expression of genes involved in fatty acid oxidation in human peripheral blood mononuclear cells and HepG2 cells.
Impact of n-3 fatty acids on endothelial function: results from human interventions studies.
Exploring newer cardioprotective strategies: ?-3 fatty acids in perspective.
Fish oil for the treatment of cardiovascular disease.
Mercury concentrations and omega-3 fatty acids in fish and shrimp: Preferential consumption for maximum health benefits.
Effect of omega-3 fish oil on cardiovascular risk in diabetes.
Fatty fish, marine omega-3 fatty acids and incidence of heart failure.
Omega-3 oil intake during weight loss in obese women results in remodelling of plasma triglyceride and fatty acids.
N-3 fatty acids and cardiac autonomic function in humans.
Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability.
Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients.
Omega-3 fatty acids in critical illness.
Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.
Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial.
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.
Pharmacotherapy of mixed dyslipidemia in the metabolic syndrome.
Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.
Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients.
The effect of N-3 fatty acids on plasma myeloperoxidase levels in healthy adults.
Fatty acids and obesity.
Effects of dietary polyunsaturated fatty acids on mitochondria.
Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta.